To study the mechanism by which HIV-1 infects neurons we have used human neuroblastoma cell lines (NB). NB (SK-N-SH and SK-N-MC) were found to be susceptible to productive infection by X4 or R5 HIV-1, as detected by viral load and Ag-p24. To identify the putative receptor, we tested the cell surface expression of previously described receptors such as CD4, nucleolin, galactosylceramide, and CCR1, CCR5, and CXCR4 by cytometry and RT-PCR. NB express no CD4 and low levels of galactosylceramide or nucleolin. Furthermore, antibodies to any of these molecules did not affect NB infection. NB express variable levels of CCR5, CCR1, and CXCR4. Interestingly, exogenous heparan sulfate alone was able to substantially inhibit HIV-1 infection, an effect which was potentiated by RANTES or SDF-1 in the HIV-1-infection with R5 or X4 isolates. Besides, anti-CCR5 and anti-CXCR4 significantly blocked HIV-1 infection of R5 and X4 isolates. Our results suggest that HIV-1 entry involves a chemokine-receptor-dependent but CD4-independent entry in neural cells.
INTRODUCTION
It has been reported that 40 to 50% of acquired immunodeficiency syndrome (AIDS) patients, both adults and children, have neurologic complications, which are directly attributable to infection of the brain by the human immunodeficiency virus type 1 (HIV-1) (Bacellar et al., 1994; Lipton, 1994) . Brain HIV-1 infection may result in a syndrome of profound cognitive, behavioral, and motor impairment termed the AIDS dementia complex in adults (Janssen et al., 1989) and HIV-1-related encephalopathy in children. The underlaying cause of HIV-1 dementia is unknown, but since productive HIV-1 infection in the central nervous system (CNS) occurs mostly in microglia, or brain macrophages, it is generally thought that these cells play a key role in the development of neurological abnormalities. HIV-1-infected neurons have been described in brains from AIDS patients (Budka, 1989; Nuovo et al., 1994) and primary human neuroblasts as well as neuronal cell lines can be infected by HIV-1 "in vitro" (Ensoli et al., 1995; Obregon et al., 1999) . Traditionally, HIV-1 dementia has been reported to be the consequence of neuronal damage or dysfunction resulting from the release of putative neurotoxic products by infected microglia or, alternatively, by neuronal interaction with viral proteins released or expressed by the infected cells. On the other hand, CNS disorders are more frequent and severe, particularly in infants and children, suggesting that a developing CNS is more vulnerable to HIV-1 (Belman, 1994; Epstein et al., 1986) .
Infection of T lymphocytes by HIV-1 requires the presence of the CD4 surface molecule, which serves as the virus receptor (Maddon et al., 1986) . However, HIV-1 infects some cells that do not express CD4, including some brain-derived glial and neuronal cells as well as retinal cells, brain capillary endothelial cells, human skin fibroblast, muscle-and bone-derived fibroblastoid cell lines, human trophoblast cells, follic- 
